Equity Overview
Price & Market Data
Price: $29.96
Daily Change: +$0.92 / 3.07%
Daily Range: $29.08 - $30.56
Market Cap: $563,111,040
Daily Volume: 87,835
Performance Metrics
1 Week: -3.85%
1 Month: -12.59%
3 Months: 44.41%
6 Months: 95.53%
1 Year: 102.6%
YTD: 42.47%
Company Details
Employees: 60
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.